Non-invasive Assessment of Dorsiflexor Muscle Function in Mice
January 17th, 2019
13.3K views
Measurement of rodent skeletal muscle contractile function is a useful tool that can be used to track disease progression as well as efficacy of therapeutic intervention. We describe here the non-invasive, in vivo assessment of the dorsiflexor muscles that can be repeated over time in the same mouse.
Overview
This article describes a non-invasive, in vivo method for assessing rodent skeletal muscle contractile function, particularly focusing on dorsiflexor muscles. This technique allows for repeated measurements over time to track disease progression and evaluate therapeutic interventions.
Key Study Components
Area of Science
- Neuroscience
- Muscle Physiology
- Neuromuscular Diseases
Background
- Understanding muscle contraction is crucial for studying neuromuscular diseases.
- Non-invasive techniques provide a way to monitor changes over time.
- Consistent results are essential for reliable data interpretation.
- This method can be applied to the same animal across multiple time points.
Purpose of Study
- To develop a reliable method for measuring muscle function in rodents.
- To facilitate the study of disease progression in neuromuscular conditions.
- To evaluate the efficacy of therapeutic interventions over time.
Methods Used
- Setup of a mouse knee clamp and footplate on a transducer.
- Application of Isoflurane for anesthesia during the procedure.
- Placement of electrodes for stimulation of the Peroneal nerve.
- Monitoring of force production through dynamic muscle control software.
Main Results
- Consistent force production values were observed across multiple time points.
- The technique demonstrated reliability between different mice.
- Data showed stable peak force measurements with proper electrode placement.
Conclusions
- This method is effective for tracking muscle function in disease models.
- It allows researchers to monitor temporal changes in muscle performance.
- Visual demonstration of the procedure is critical for reproducibility.
Frequently Asked Questions
What is the main advantage of this technique?
The main advantage is that it is a non-invasive method that allows for repeated measurements on the same animal.
How does this method contribute to neuromuscular disease research?
It enables researchers to monitor disease progression and evaluate treatment efficacy over time.
What are the key steps in the procedure?
Key steps include preparing the mouse, setting up the equipment, and monitoring muscle contractions.
Why is electrode placement important?
Proper electrode placement is crucial for achieving maximum stimulation of the Peroneal nerve and accurate measurements.
How often can this procedure be repeated?
The procedure can be repeated weekly to track changes in muscle function over time.
What type of data is collected during the procedure?
Data on force production and frequency curves are collected to assess muscle function.
Executive Industry Relevance
Non-invasive, longitudinal assessment of skeletal muscle contractile function enables early detection of functional decline in preclinical disease models. This approach supports mechanistic de-risking by providing quantitative, repeatable readouts of neuromuscular integrity, reducing reliance on terminal endpoints. It enhances predictive confidence in target validation by linking molecular interventions to functional outcomes across time.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses related to force production mechanisms in neuromuscular pathways.
- Operational Value: Supports biological de-risking through repeated, non-terminal measurements of muscle function in the same animal.
- Predictive Value: Facilitates portfolio triage by correlating target modulation with functional preservation across disease progression.
Screening & Assay Development
- Assay Readiness: Prepares validated neuromuscular systems for compound screening via standardized force-frequency curve generation.
- Reproducibility: Ensures consistent stimulation parameters and electrode placement for reliable longitudinal data.
- Scalability: Enables platform reuse across multiple time points and disease models with minimal animal usage.
Translational & Preclinical Research
- Disease Relevance: Mirrors clinical assessment of dorsiflexor function in conditions like sarcopenia and neuropathy.
- Translational Continuity: Bridges discovery to preclinical validation by tracking functional biomarkers over time.
- Risk-Adjusted Decisions: Informs advancement criteria based on sustained functional improvement rather than isolated terminal measures.
Pipeline & Workflow Integration
This method integrates into the discovery continuum from target validation through lead optimization, providing functional endpoints that complement molecular and histological assessments.
- Discovery Biology: Supports hypothesis testing of neuromuscular targets by quantifying functional output in vivo.
- Screening: Delivers quantitative, reproducible force measurements enabling dose-response and temporal profiling.
- Analytics: Generates force-frequency curves as integrative readouts of excitation-contraction coupling and neuromuscular efficacy.
- Translational Research: Aligns with clinical functional assessments, supporting biomarker qualification efforts.
- Enterprise Reuse: Establishes a reusable capability for longitudinal neuromuscular phenotyping across therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in muscle function.
- Operational Value: Enhances standardization and reproducibility through non-invasive, repeatable procedures.
- Strategic Value: Improves go/no-go decisions by enabling early functional readouts that reduce late-stage failure risk.
- Portfolio Impact: Supports risk-adjusted prioritization through objective, longitudinal functional data.
Implementation Considerations
- Requires expertise in neuromuscular stimulation and electrophysiology setup.
- Depends on calibrated transducers, stimulators, and temperature-controlled platforms.
- Necessitates standardized electrode placement protocols to minimize inter-operator variability.
- Involves adaptation considerations for different mouse strains and disease models affecting limb morphology.
- Limited to superficial nerve-accessible muscle groups; deep tissue assessment requires alternative approaches.
Biopharma FAQs
Why does force frequency curve analysis matter for target validation?
Force frequency curve analysis quantifies the relationship between stimulation intensity and muscle force, enabling assessment of excitation-contraction coupling integrity. This provides a functional readout that helps validate whether a target modulates neuromuscular signaling pathways. Longitudinal tracking of these curves supports de-risking by distinguishing symptomatic from disease-modifying effects.
How does isolation of stimulation variables support the discovery pipeline?
Isolating variables such as electrode placement, stimulation voltage, and nerve specificity ensures that observed changes in force are attributable to biological interventions rather than technical artifacts. This control is essential for establishing causal links between target modulation and functional outcomes. Standardized variable isolation enhances reproducibility across laboratories and study phases.
What do quantitative dependent variable measurements enable in preclinical studies?
Quantitative measurements of dorsiflexor torque and force-frequency relationships enable objective comparison of muscle function across time, treatment groups, and genotypes. These data support statistical modeling of disease progression and therapeutic efficacy. Continuous variables allow for sensitive detection of subtle functional changes before overt pathology develops.
Why do replication requirements matter for cross-functional collaboration?
Replication across time points and animals ensures that observed functional changes are robust and not due to procedural variability or animal-specific factors. This reliability is critical when translating findings between discovery, toxicology, and clinical teams. Consistent replication builds confidence in the assay as a shared resource for go/no-go decisions.
What statistical analysis capabilities are required before implementing this method?
Implementation requires the ability to analyze repeated-measures data, including within-subject correlations across time points and between-group comparisons. Capabilities for curve fitting, area-under-the-curve calculations, and longitudinal modeling are necessary to extract meaningful trends from force-frequency data. These analyses enable detection of non-linear progression and treatment effects over time.
